课题基金 / 基金详情

GANDALF - GAllium Nitride process De-risk for uk Automotive suppLy chains -- a Feasibility study

GANDALF - GAllium Nitride process De-risk for uk Automotive suppLy chains -- a Feasibility study
甘道夫 - 氮化镓工艺降低英国汽车供应链的风险 - 可行性研究
批准号:
82741
负责人:
金额:
$12.99万
依托单位国家:
英国
项目类别:
BEIS-Funded Programmes
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
这是一个工业主导的项目,合作伙伴评估利用现有DER快速启动项目(105891)启动的WBG制造能力在英国制造Nexperia最新一代D模式650 V GaN器件的可行性。这个为期5个月的项目将提供200毫米工艺定义(外延和晶圆厂),转移规格和任何相关的技术风险降低。双方将在NDA下就以下方面交换技术信息:* 650 V GaN on silicon HEMT的外延结构。* Nexperia专有工艺的工艺流程要求 * 关键性能规格和资质要求这项工作是建立可扩展的英国GaN材料和芯片制造能力的长期目标的重要第一阶段,这也将支持Nexperia GaN业务的未来增长目标。成功交付将使Nexperia未来的需求(到2027年每月5000片晶圆)从海外重新回到英国(外延和芯片工厂),并从150毫米转移到200毫米晶圆。交付全部能力所需的其他阶段包括:* 第2阶段:制造概念验证,包括关键资本设备的部署 * 第3阶段:产能提升至1 kwpm-包括资本 * 第4阶段:产能提升至5 kwpm--包括资本它还将通过加速和减少产能来显著扩大项目(105891)的范围,风险的下一阶段提供完整的外延和芯片制造能力的200毫米GaN硅,650 V HEMT。三个工业合作伙伴的互补能力提供了英国最可靠的路线,成本竞争力,200 mm WBG解决方案,可扩展以满足英国汽车供应链不断增长的需求。长期的项目优势包括:* Nexperia可以在CSC的外延产品(目前使用海外供应商)上评估其GaN器件性能,并启动从150 mm到200 mm的工艺过渡。* NWF将通过他们的晶圆厂运行Nexperia的测试车辆,并显着降低后续工艺转移的风险。* CSC将为Nexperia验证其200 mm外延晶圆产品,使其能够按照Nexperia的预测实现显著增长。英国汽车供应链获得了最先进的WBG前端能力,即材料,工艺和包装的一站式商店。它还为英国合作伙伴提供了大量的商业机会,否则他们将走向海外。所有合作伙伴都同意这个可行性项目在5个月内可以管理,并准备在2020年11月1日之前开始。
英文摘要
This is a industrial led project in which the partners assess the feasibility of exploiting the WBG manufacturing capability initiated under an existing DER Fast Start project (105891) to manufacture Nexperia's latest generation of D-mode 650V GaN devices in the UK. This 5 month project will deliver a 200mm process definition (epitaxy and fab), transfer specifications and any relevant technical de-risking. Mutual technical information exchange will be exchanged under NDA on:* The epitaxial structure of the 650V GaN on silicon HEMT.* Process flow requirements of Nexperia's proprietary process* Key performance specifications and qualification requirementsThis work is a vital first phase of a longer term ambition to establish a scalable UK capability in GaN materials and chip manufacturing that will also support the future growth ambitions of Nexperia's GaN business. Successful delivery would enable Nexperia's future demand (5000 wafers per month by 2027) to be reshored to the UK (epitaxy and chip fab) from overseas with the additional benefit of being transferred from 150mm to 200mm wafers. The additional phases needed to deliver the full capability are:* Phase 2: Proof of manufacturing concept including deployment of critical capital equipment* Phase 3: Capacity ramp to 1kwpm - including capital* Phase 4: Capacity ramp to 5kwpm -- including capitalIt will also significantly expand the scope of project (105891) by both accelerating and de-risking the next stages of delivering a full epitaxy and chip manufacturing capability for 200mm GaN on Si, 650V HEMTs.The complementary capabilities of the three industrial partners provide the UK's most credible route for a cost competitive, 200mm WBG solution that can scale to meet the growing demands of the UK automotive supply chain. Longer-term project benefits include:* Nexperia can evaluate it's GaN device performance on CSC's epitaxy offering (currently using overseas suppliers) and initiate the process transition from 150mm to 200mm.* NWF will run Nexperia's test vehicle through their fab and significantly de-risk the subsequent process transfer.* CSC will validate their 200mm epitaxial wafer products for Nexperia to position them for significant growth in line with Nexperia's forecasts.* The UK automotive supply chain gains a state of the art WBG front end capability i.e. a one-stop shop in Materials, Process and Packaging. It also secures a high volume business opportunity for UK partners which would otherwise go overseas.All partners agree this feasibility project is manageable within 5 months and are ready to start by 1st November 2020\.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金